Volume 33, Issue 1 (11-2023)                   J Mazandaran Univ Med Sci 2023, 33(1): 321-326 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Habibi M, Sarabandi A, Soleymani A, Yazdani Cherati J, Habibi V, Nouraei S M et al . Cardio Protective Effects of Propofol against Ischemic/Reperfusion Injury following Coronary Artery Bypass Graft (CABG). J Mazandaran Univ Med Sci 2023; 33 (1) :321-326
URL: http://jmums.mazums.ac.ir/article-1-20013-en.html
Abstract:   (251 Views)
Background and purpose: Despite cardioprotective strategies against ischemia/reperfusion injury following coronary artery bypass graft (CABG), its complications still exist. Therefore, the present study aimed to determine the cardioprotective effects of propofol against ischemic/reperfusion injury following CABG.
Materials and methods: In this double-blind clinical trial study, 70 patients undergoing CABG were admitted to Fatemeh Zahra Hospital, Sari, Iran, 2017 were evaluated. The participants were divided into two groups of the anesthetic induction group with the combination of propofol, midazolam, fentanyl, and ether and the anesthetic induction group with nesdonal, midazolam, fentanyl, and ether. The data were registered in the checklist made by the researcher. The data were analyzed by SPSS software using descriptive and analytical statistical tests.
Results: An increase in the level of creatinine and C-reactive protein was observed in both study groups from the time of opening the aortic clamp until 15 min after, and a decrease in the ventricular ejection fraction from before surgery to 48 h post-surgery(P<0.05). An increase in troponin level was reported only in the anesthetic induction group with propofol, midazolam, fentanyl, and ether (P=0.04).
Conclusion: Considering the increased levels of creatinine, troponin, serum C-reactive protein, and the decrease in ventricular ejection fraction in the propofol combination group, this drug is not superior in reducing ischemia/reperfusion injury compared to the nasedonal combination.
Full-Text [PDF 607 kb]   (93 Downloads)    
Type of Study: Brief Report | Subject: anesthesia

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Mazandaran University of Medical Sciences

Designed & Developed by : Yektaweb